Dapoflit 10 Tablet is a highly effective antidiabetic medication containing Dapagliflozin 10mg, a sodium-glucose co-transporter-2 (SGLT2) inhibitor. It is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. By reducing glucose reabsorption in the kidneys, Dapagliflozin facilitates the elimination of excess glucose through urine, leading to better glycemic control.
In addition to lowering blood sugar, Dipodart 10 Tablet offers multiple benefits. It aids in weight reduction and has shown to improve cardiovascular outcomes in patients at risk of or with pre-existing heart conditions. It can also reduce the progression of diabetic kidney disease, making it an essential component in comprehensive diabetes management.
Dapoflit 10 Tablet is suitable for standalone therapy or in combination with other antidiabetic agents, such as metformin or insulin. This flexibility allows healthcare providers to tailor treatment plans to individual patient needs. With consistent use as prescribed, it can significantly lower the risk of complications associated with type 2 diabetes, including cardiovascular diseases, neuropathy, and nephropathy.
This medication falls under Antidiabetic, Diabetic, and Endocrinology and Hormonal Range therapies. It plays a vital role in enhancing the quality of life for patients managing chronic diabetes while supporting broader health outcomes.